Sensera (ASX:SE1), a sensor manufacturer and player in the Internet of Things (IoT) market, has disclosed its supply agreement announced on Monday is with Abiomed, a US-based medical device company.
The multimillion dollar agreement with Sensara’s US subsidiary spans three years as a supplier to Abiomed.
The deal embeds Sensera as a part of the supply chain for Abiomed for its medical device that leads its customer portfolio.
Abiomed has a market cap of US$8 billion and produces a number of medical devices including the world’s smallest heart pump.
Sensera Executive Chairman Matt Morgan said manufacturing for this customer will play a meaningful role in delivering year on year revenue growth for the company.
Shares in Sensera (ASX:SE1) closed 2.78 per cent lower to 35 cents a share.